Table 6 List of differentially expressed genes with at least twofold change obtained from comparisons of no recurrence vs recurrence in the TNT group
Illumina ID | Log2 FC | P-value | ENTREZ | Symbol | Description |
|---|---|---|---|---|---|
Upregulated genes in no recurrence vs recurrence comparisons | |||||
ALB | 3.40 | 0.022763 | 213 | ALB | Homo sapiens albumin (ALB), mRNA |
LOC647450 | 2.71 | 0.014532 | 647450 | LOC647450 | Predicted: homo sapiens similar to Ig κ chain V-I region HK101 precursor (LOC647450), mRNA |
LOC652493 | 2.68 | 0.012371 | 652493 | LOC652493 | Predicted: homo sapiens similar to Ig κ chain V-I region HK102 precursor (LOC652493), mRNA |
LOC651751 | 2.57 | 0.000492 | 651751 | LOC651751 | Predicted: homo sapiens similar to Ig κ chain V-II region RPMI 6410 precursor (LOC651751), mRNA |
CEACAM6 | 2.57 | 0.031912 | 4680 | CEACAM6 | Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 6 (nonspecific cross-reacting antigen) (CEACAM6), mRNA |
LOC642113 | 2.41 | 0.01145 | 642113 | LOC642113 | Predicted: homo sapiens similar to Ig κ chain V–III region HAH precursor (LOC642113), mRNA |
LOC652694 | 2.39 | 0.002864 | 652694 | LOC652694 | Predicted: homo sapiens similar to Ig κ chain V–I region HK102 precursor (LOC652694), mRNA |
HLA-DRB5 | 2.38 | 0.029661 | 3127 | HLA-DRB5 | Homo sapiens major histocompatibility complex, class II, DR β 5 (HLA-DRB5), mRNA |
LOC649923 | 2.16 | 0.006045 | 649923 | LOC649923 | Predicted: homo sapiens similar to Ig gamma-2 chain C region (LOC649923), mRNA |
LOC652775 | 2.01 | 0.002943 | 652775 | LOC652775 | Predicted: homo sapiens similar to Ig κ chain V–V region L7 precursor (LOC652775), mRNA |
LOC652102 | 1.74 | 0.000466 | 652102 | LOC652102 | Predicted: homo sapiens similar to Ig heavy chain V–I region HG3 precursor (LOC652102), mRNA |
IGLL1 | 1.62 | 0.014304 | 3543 | IGLL1 | Homo sapiens immunoglobulin λ-like polypeptide 1 (IGLL1), transcript variant 2, mRNA |
ACOX2 | 1.60 | 0.000967 | 8309 | ACOX2 | Homo sapiens acyl-coenzyme A oxidase 2, branched chain (ACOX2), mRNA |
MGC29506 | 1.59 | 0.014185 | 51237 | MGC29506 | Homo sapiens hypothetical protein MGC29506 (MGC29506), mRNA |
HLA-DQA1 | 1.51 | 0.015729 | 3117 | HLA-DQA1 | Predicted: homo sapiens major histocompatibility complex, class II, DQ α 1, transcript variant 10 (HLA-DQA1), mRNA |
LYZ | 1.47 | 0.042465 | 4069 | LYZ | Homo sapiens lysozyme (renal amyloidosis) (LYZ), mRNA |
HLA-DRB4 | 1.46 | 0.013791 | 3126 | HLA-DRB4 | Homo sapiens major histocompatibility complex, class II, DR β 4 (HLA-DRB4), mRNA |
HLA-DRA | 1.44 | 0.023102 | 3122 | HLA-DRA | Homo sapiens major histocompatibility complex, class II, DR α (HLA-DRA), mRNA |
SLC5A1 | 1.39 | 0.021721 | 6523 | SLC5A1 | Homo sapiens solute carrier family 5 (sodium/glucose cotransporter), member 1 (SLC5A1), mRNA |
HLA-DMA | 1.39 | 0.009901 | 3108 | HLA-DMA | Homo sapiens major histocompatibility complex, class II, DM α (HLA-DMA), mRNA |
GZMK | 1.36 | 0.014311 | 3003 | GZMK | Homo sapiens granzyme K (granzyme 3; tryptase II) (GZMK), mRNA |
C6ORF192 | 1.34 | 0.027143 | 116843 | C6ORF192 | Homo sapiens chromosome 6 open reading frame 192 (C6orf192), mRNA |
SOSTDC1 | 1.30 | 0.007454 | 25928 | SOSTDC1 | Homo sapiens sclerostin domain containing 1 (SOSTDC1), mRNA |
MGP | 1.24 | 0.047067 | 4256 | MGP | Homo sapiens matrix Gla protein (MGP), mRNA |
LOC644151 | 1.24 | 0.013498 | 644151 | LOC644151 | Predicted: homo sapiens similar to calpain 8 (LOC644151), mRNA |
CAMK1G | 1.21 | 0.00353 | 57172 | CAMK1G | Homo sapiens calcium/calmodulin-dependent protein kinase IG (CAMK1G), mRNA |
HLA-DRB3 | 1.21 | 0.016937 | 3125 | HLA-DRB3 | Homo sapiens major histocompatibility complex, class II, DR β 3 (HLA-DRB3), mRNA |
FAM46C | 1.20 | 0.020803 | 54855 | FAM46C | Homo sapiens family with sequence similarity 46, member C (FAM46C), mRNA |
HLA-DMB | 1.18 | 0.009027 | 3109 | HLA-DMB | Homo sapiens major histocompatibility complex, class II, DM β (HLA-DMB), mRNA |
CFD | 1.17 | 0.043992 | 1675 | CFD | Homo sapiens complement factor D (adipsin) (CFD), mRNA |
VIPR1 | 1.17 | 0.007108 | 7433 | VIPR1 | Homo sapiens vasoactive intestinal peptide receptor 1 (VIPR1), mRNA |
JSRP1 | 1.16 | 0.000782 | 126306 | JSRP1 | Homo sapiens junctional sarcoplasmic reticulum protein 1 (JSRP1), mRNA |
HLA-DRB6 | 1.14 | 0.037486 | 3128 | HLA-DRB6 | Homo sapiens major histocompatibility complex, class II, DR β 6 (pseudogene) (HLA-DRB6), non-coding RNA |
CPVL | 1.09 | 0.022705 | 54504 | CPVL | Homo sapiens carboxypeptidase, vitellogenic-like (CPVL), transcript variant 1, mRNA |
MYB | 1.08 | 0.026033 | 4602 | MYB | Homo sapiens v-myb myeloblastosis viral oncogene homolog (avian) (MYB), transcript variant 2, mRNA |
PIM2 | 1.05 | 0.002093 | 11040 | PIM2 | Homo sapiens pim-2 oncogene (PIM2), mRNA |
CD79A | 1.01 | 0.005757 | 973 | CD79A | Homo sapiens CD79a molecule, immunoglobulin-associated α (CD79A), transcript variant 1, mRNA |
LPXN | 1.01 | 0.015139 | 9404 | LPXN | Homo sapiens leupaxin (LPXN), mRNA |
Downregulated genes no recurrence vs recurrence comparisons | |||||
CASC3 | −1.10 | 0.04282 | 22794 | CASC3 | Homo sapiens cancer susceptibility candidate 3 (CASC3), mRNA |
SNCG | −1.26 | 0.00869 | 6623 | SNCG | Homo sapiens synuclein, gamma (breast cancer-specific protein 1) (SNCG), mRNA |
HIST1H2BD | −1.35 | 0.008322 | 3017 | HIST1H2BD | Homo sapiens histone cluster 1, H2bd (HIST1H2BD), transcript variant 2, mRNA |
HIST1H4H | −1.52 | 0.005711 | 8365 | HIST1H4H | Homo sapiens histone cluster 1, H4 h (HIST1H4H), mRNA |
ERBB2 | −1.66 | 0.037147 | 2064 | ERBB2 | Homo sapiens v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 2, mRNA |
PNMT | −1.87 | 0.028033 | 5409 | PNMT | Homo sapiens phenylethanolamine N-methyltransferase (PNMT), mRNA |